Since their discovery over a decade ago, MXenes have transformed the field of “materials for healthcare”, stimulating growing interest in their healthcare-related applications. These developments have also driven significant advancements in MXenes’ synthesis. This review systematically examines the synthesis of MXenes and their applications in sensing and biomedical fields, underscoring their pivotal role in addressing critical challenges in modern healthcare. We describe the experimental synthesis of MXenes by combining appropriate laboratory modules with the mechanistic principles underlying each synthesis step. In addition, we provide extensive details on the experimental parameters, critical considerations, and essential instructions for successful laboratory synthesis. Various healthcare applications including sensing, biomedical imaging, synergistic therapies, regenerative medicine, and wearable devices have been explored. We further highlight the emerging trends of MXenes, viz., their role as nanovehicles for drug delivery, vectors for gene therapy, and tools for immune profiling. By identifying the important parameters that define the utility of MXenes in biomedical applications, this review outlines strategies to regulate their biomedical profile, thereby serving as a valuable guide to design MXenes with application-specific properties. The final section integrates experimental research with theoretical studies to provide a comprehensive understanding of the field. It examines the role of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), in accelerating material discovery, structure–property optimization, and automation. Complemented by detailed supplementary information on synthesis, stability, biocompatibility, environmental impact, and theoretical insights, this review offers a profound knowledge base for understanding this diverse family of 2D materials. Finally, we compared the potential of MXenes with that of other 2D materials to underscore the existing challenges and prioritize interdisciplinary collaboration. By synthesizing key studies from its discovery to current trends (especially from 2018 onward), this review provides a cohesive assessment of MXene synthesis with theoretical foundations and their prospects in the healthcare sector.

Graphene-based materials are of interest in electrochemical biosensing due to their unique properties, such as high surface areas, unique electrochemical properties, and biocompatibility. However, the scalable production of graphene electrodes remains a challenge; it is typically slow, expensive, and inefficient. Herein, we reported a simple, fast, and maskless method for large-scale, low-cost reduced graphene oxide electrode fabrication; using direct writing (laser scribing and inkjet printing) coupled with a stamp-transferring method. In this process, graphene oxide is simultaneously reduced and patterned with a laser, before being press-stamped onto polyester sheets. The transferred electrodes were characterized by SEM, XPS, Raman, and electrochemical methods. The biosensing utility of the electrodes was demonstrated by developing an electrochemical test for Escherichia coli. These biosensors exhibited a wide dynamic range (917-2.1 × 10⁷ CFU/mL) of low limits of detection (283 CFU/mL) using just 5 μL of sample. The test was also verified in spiked artificial urine, and the sensor was integrated into a portable wireless system driven and measured by a smartphone. This work demonstrates the potential to use these biosensors for real-world, point-of-care applications. Hypothetically, the devices are suitable for the detection of other pathogenic bacteria.

Simplicity is one of the key feature for the spread of any successful technological product. Here, a method for rapid and low-cost fabrication of electrochemical biosensors is presented. This "plug, print & play" method involves inkjet-printing even in an office-like environment, without the need of highly specialized expertise or equipment, guaranteeing an ultra-fast idea to (scaled) prototype production time. The printed biosensors can be connected to a smartphone through its audio input for their impedance readout, demonstrating the validity of the system for point-of-care biosensing. Proper electrodes layout guarantees high sensitivity and is validated by finite element simulations. The introduction of a passivation method (wax printing) allowed to complete the devices fabrication process, increasing their sensitivity. Indeed, the wax allowed reducing the interference related to the parasitic currents flowing through the permeable coating of the employed substrates, which was used for the chemical sintering, thus avoiding the common thermal treatment after printing. As a case study, we used the devices to develop an electrochemical aptamer-based sensor for the rapid detection of neutrophil gelatinase-associated lipocalin (NGAL) in urine - a clinically important marker of acute kidney injury. The aptasensor platform is capable of detecting clinically relevant concentrations of NGAL with a simple and rapid smartphone readout. The developed technology may be extended in the future to continuous monitoring, taking advantage of its flexibility to integrate it in tubes, or to other diagnostic applications where cost/efficiency and rapidity of the research, development and implementation of point of care devices is a must.